title: Avoidance of perioperative renal toxicity by a modified immunosuppression protocol.
authors.affiliation: Department of Surgery, University of Pittsburgh School of Medicine, PA 15261.
authors.forename: R L
authors.initials: RL
authors.lastname: Kormos
authors.forename: A
authors.initials: A
authors.lastname: Trento
authors.forename: R L
authors.initials: RL
authors.lastname: Hardesty
authors.forename: B P
authors.initials: BP
authors.lastname: Griffith
authors.forename: M
authors.initials: M
authors.lastname: Thompson
authors.forename: H T
authors.initials: HT
authors.lastname: Bahnson
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine